Skip to main content
Normal View

Health Services

Dáil Éireann Debate, Wednesday - 14 February 2024

Wednesday, 14 February 2024

Questions (310, 311, 312, 313, 314, 315, 316, 317)

Patrick Costello

Question:

310. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 523 of 30 January 2024, the risks and benefits of GnRHa alone for adults, and what sort of patients would choose this treatment from the National Gender Services. [6843/24]

View answer

Patrick Costello

Question:

311. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 525 of 30 January 2024, how many referrals the National Gender Service's referral process triaged as "New Gender Clinic" in 2023. [6844/24]

View answer

Patrick Costello

Question:

312. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 526 of 30 January 2024, if the National Gender Service believes the that use of GnRHa makes cisgender children transgender. [6845/24]

View answer

Patrick Costello

Question:

313. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 526 of 30 January 2024, which clinical studies show that gender non-conforming children largely turn out to be cisgender in adolescence, and if the National Gender Service believe this represents the current best evidence for the outcomes for pre-pubertal transgender children. [6846/24]

View answer

Patrick Costello

Question:

314. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 528 of 30 January 2024, the reason the National Gender Service's endocrine guidelines emphasise that high hormone concentrations elevate the risks of thromboembolic and liver disease. [6847/24]

View answer

Patrick Costello

Question:

315. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 528 of 30 January 2024, why the National Gender Service requires regular hormone concentration blood tests for its own patients given that it listed no harms or benefits for them, and if these could be cut as a cost saving measure. [6848/24]

View answer

Patrick Costello

Question:

316. Deputy Patrick Costello asked the Minister for Health further to Parliamentary Question No. 528 of 30 January 2024, if the National Gender Service is aware that under EU Directive 2011/24, there is no requirement for EU telehealth services to be regulated in Ireland as they are considered to be provided, and thus regulated in the doctor's country. [6849/24]

View answer

Patrick Costello

Question:

317. Deputy Patrick Costello asked the Minister for Health if he is aware of a recent report (details supplied) that the National Gender Service's waiting list now exceeds a decade; and if he will make a statement on the matter. [6850/24]

View answer

Written answers

I propose to take Questions Nos. 310 to 317, inclusive, together.

As this is a service matter I have referred the question to the HSE for direct reply to the Deputy.

Question No. 311 answered with Question No. 310.
Question No. 312 answered with Question No. 310.
Question No. 313 answered with Question No. 310.
Question No. 314 answered with Question No. 310.
Question No. 315 answered with Question No. 310.
Question No. 316 answered with Question No. 310.
Question No. 317 answered with Question No. 310.
Top
Share